The country is becoming a major destination for the corona epidemic that is trading the world. Bharat Biotech, which has made the Kovid vaccine available, is going to alleviate their ‘Kovaggin’ vaccine.
Bharat Biotech covaxin: The country is becoming a major destination for the corona epidemic that is trading the world. Bharat Biotech, which has made the Kovid vaccine available, is going to alleviate their ‘Kovaggin’ vaccine. It is preparing to supply the vaccine to forty countries. Company sources said that they have applied for the necessary permits to distribute the vaccine to those countries. “We are ready to supply the vaccine to Brazil and many other countries and have applied for the necessary permits,” the sources said. However, the cost of vaccination depends on the country, the time of delivery and many other factors.
It is learned that some doses of Kovaggin vaccine have already been provided to India Biotech, Brazil and UAE. The company is also ready to supply the vaccine to the Philippines, Bangladesh and other countries. Representatives of the company said that India Biotech has entered into an agreement with a US company called Oxygen to supply Kovaggin in the US. It is learned that Mumma is making efforts to supply the vaccine to various countries wherever possible.
The third phase of clinical trials on covagin, which is currently underway in the country, is expected to be completed by the end of next month. After that it seems likely that the vaccine will be widely available, in order to obtain full approvals. At present the government in our country has given permission for the urgent use of this vaccine in the form of clinical trials. In addition, the government purchased one crore doses of the vaccine in two installments. The vaccine is currently being offered to Frontline Warriors Health Workers on a priority basis.
Read Also ప్రభుత్వం Government takes key decision to attract tourists .. Travancore project with Rs 100 crore .. Wherever ..